Announcements Trials

Browse Landscape

Phase

Phase 1/2 9 Phase 3 8 Phase 2 8 Phase 1 4 Phase NA 1 Phase 4 1

Status

Sponsor Class

OTHER 29 NIH 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Mammography 12 Radiofrequency Ablation 9 Blood Specimen Collection 9 Standard of Care 8 Drug Delivery Systems 8 Colonoscopy 8 Uterine Myomectomy 6 Robotic Surgical Procedures 6 Cryosurgery 6 Colposcopy 6 Biopsy 6 Proton Therapy 5 Inositol 5 Therapeutics 4 Surgical Procedures, Operative 4 Radiotherapy 4 Leukapheresis 4 Food 4 Drug Therapy 4 Cryotherapy 4 Cisplatin 4 CF regimen 4 Brachytherapy 4 pegylated granulocyte colony-stimulating factor 3 exemestane 3 epigallocatechin gallate 3 Uterine Artery Embolization 3 Sunitinib 3 Paclitaxel 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × INDUSTRY × Melphalan × Clear all

NCT01572688 2012-08-02

MM

Shandong Lanjin Pharmaceuticals Co.,Ltd

Phase NA Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡